---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-031742"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T05:57:00.503868+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TuHURA receives Nasdaq delisting notice for bid price below $1.00; 180-day cure period until July 2026

## Summary
- Nasdaq letter on Jan 29, 2026, for bid price <$1.00 for 35 consecutive days, violating Listing Rule 5550(a)(2).
- Company has 180-day grace period, until July 28, 2026, to regain compliance by closing bid price ≥$1.00 for 10 consecutive days.
- If not compliant by July 28, a second 180-day period may be available if other listing standards are met.
- Company will monitor bid price and consider options, including a potential reverse stock split to regain compliance.

## SEC filing metadata
- accession: 0001193125-26-031742
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312526031742/0001193125-26-031742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312526031742/hura-20260129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-031742
- JSON: https://secwatch.observer/filing/0001193125-26-031742.json
- Plain text: https://secwatch.observer/filing/0001193125-26-031742.txt

## Source-grounded claims
- claim_id: 9c5d01fdb8bce1f935abb2d08fbd2629e284126d
  claim: TuHURA Biosciences, Inc./NV received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: January 29, 2026, TuHURA Biosciences, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s consolidated closing bid price has been below $1.00 per share for 35 consecutive business days as of January 28, 2026, and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which is the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. Pursuant to Nasdaq Listing R
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000119312526031742/0001193125-26-031742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.